NEW YORK (GenomeWeb) – Alere announced this week that it will initiate a voluntary withdrawal of its anti-coagulation monitoring INRatio and INRatio2 PT/INR Monitoring System. The company said it is working with the US Food and Drug Administration to determine the most appropriate timing to discontinue the product, and will provide guidance on transitioning patients to an alternate product.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.